Title |
Immune-checkpoint inhibitors: long-term implications of toxicity
|
---|---|
Published in |
Nature Reviews Clinical Oncology, January 2022
|
DOI | 10.1038/s41571-022-00600-w |
Pubmed ID | |
Authors |
Douglas B. Johnson, Caroline A. Nebhan, Javid J. Moslehi, Justin M. Balko |
X Demographics
The data shown below were collected from the profiles of 353 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 74 | 21% |
Spain | 17 | 5% |
Brazil | 13 | 4% |
Mexico | 11 | 3% |
United Kingdom | 9 | 3% |
India | 8 | 2% |
Italy | 7 | 2% |
France | 7 | 2% |
Colombia | 7 | 2% |
Other | 50 | 14% |
Unknown | 150 | 42% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 203 | 58% |
Scientists | 84 | 24% |
Practitioners (doctors, other healthcare professionals) | 61 | 17% |
Science communicators (journalists, bloggers, editors) | 5 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 448 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 448 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 49 | 11% |
Student > Bachelor | 45 | 10% |
Researcher | 44 | 10% |
Other | 26 | 6% |
Student > Master | 26 | 6% |
Other | 70 | 16% |
Unknown | 188 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 82 | 18% |
Biochemistry, Genetics and Molecular Biology | 64 | 14% |
Immunology and Microbiology | 28 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 3% |
Unspecified | 14 | 3% |
Other | 43 | 10% |
Unknown | 202 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 217. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2024.
All research outputs
#182,082
of 25,782,229 outputs
Outputs from Nature Reviews Clinical Oncology
#24
of 2,361 outputs
Outputs of similar age
#5,830
of 521,606 outputs
Outputs of similar age from Nature Reviews Clinical Oncology
#2
of 28 outputs
Altmetric has tracked 25,782,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,361 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 521,606 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.